September 11, 2020

Answering the Need for SARS-CoV-2 Guidance Statements

Episode 91

A discussion with COVID-19 Task Force Chairs, dermatologist Dr. Joel Gelfand and rheumatologist Dr. Christopher Ritchlin with guest host Dr. Stacie Bell Chief Scientific and Medical Officer at the National Psoriasis Foundation.

Given the pandemic and need for clarity, NPF developed a COVID-19 Task Force. Listen as Co-Chairs, dermatologist Dr. Joel Gelfand, Director, Psoriasis and Phototherapy Treatment Center at Penn, and rheumatologist Dr. Christopher Ritchlin, Co-Director, Psoriasis Center, University of Rochester Medical Center in New York, discuss the evidence and content of NPF's 22 guidance statements addressing effects, risks, and best practices for treatment of patients with psoriatic disease.

Read the NPF COVID-19 Task Force Guidance Statements.

Related Items

Stay in the Know

Expert tips, can’t-miss events, and the latest news, straight to your inbox.

National Health Council Standards of ExcellenceCharity NavigatorCommunity Health Charities logo

Copyright © 1996-2023 National Psoriasis Foundation/USA

Duplication, rebroadcast, republication, or other use of content appearing on this website is prohibited without written permission of the National Psoriasis Foundation (NPF).

NPF does not endorse or accept any responsibility for the content of external websites.

NPF does not endorse any specific treatments or medications for psoriasis and psoriatic arthritis.

We use cookies to offer you a better experience and analyze our site traffic. By continuing to use this website, you consent to the use of cookies in accordance with our Privacy Policy.